Design and synthesis of novel prostaglandin E2 ethanolamide and glycerol ester probes for the putative prostamide receptor(s).

[1]  Mireille Alhouayek,et al.  COX-2-derived endocannabinoid metabolites as novel inflammatory mediators. , 2014, Trends in pharmacological sciences.

[2]  Lauren L Nicotra,et al.  Prostaglandin ethanolamides attenuate damage in a human explant colitis model. , 2013, Prostaglandins & other lipid mediators.

[3]  S. Nikas,et al.  Enantioselective synthesis of (10S)- and (10R)-methyl-anandamides. , 2012, Tetrahedron.

[4]  A. Makriyannis,et al.  Application of Chemoenzymatic Hydrolysis in the Synthesis of 2-Monoacylglycerols. , 2012, Tetrahedron.

[5]  A. Makriyannis,et al.  Chemoenzymatic Synthesis of 2-Arachidonoylglycerol, An Endogenous Ligand for Cannabinoid Receptors. , 2011, Tetrahedron letters.

[6]  S. Nolan,et al.  The Meyer―Schuster rearrangement: a new synthetic strategy leading to prostaglandins and their drug analogs, Bimatoprost and Latanoprost , 2010 .

[7]  S. Nikas,et al.  Design and synthesis of (13S)-methyl-substituted arachidonic acid analogues: templates for novel endocannabinoids. , 2010, Chemistry.

[8]  T. Hoye,et al.  Mosher ester analysis for the determination of absolute configuration of stereogenic (chiral) carbinol carbons , 2007, Nature Protocols.

[9]  A. Makriyannis,et al.  (-)-7′-Isothiocyanato-11-hydroxy-1′,1′-dimethylheptylhexahydrocannabinol (AM841), a High-Affinity Electrophilic Ligand, Interacts Covalently with a Cysteine in Helix Six and Activates the CB1 Cannabinoid Receptor , 2005, Molecular Pharmacology.

[10]  C. Serhan.  Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  M. Mitchell,et al.  Misidentification of prostamides as prostaglandins Published, JLR Papers in Press, May 1, 2005. DOI 10.1194/jlr.C500006-JLR200 , 2005, Journal of Lipid Research.

[12]  C. Serhan,et al.  Molecular Circuits of Resolution: Formation and Actions of Resolvins and Protectins1 , 2005, The Journal of Immunology.

[13]  L. Petrocellis,et al.  Prostaglandin Ethanolamides (Prostamides): In Vitro Pharmacology and Metabolism , 2004, Journal of Pharmacology and Experimental Therapeutics.

[14]  J. Morrow,et al.  Metabolism of the Endocannabinoids, 2-Arachidonylglycerol and Anandamide, into Prostaglandin, Thromboxane, and Prostacyclin Glycerol Esters and Ethanolamides* , 2002, The Journal of Biological Chemistry.

[15]  R. Pertwee,et al.  Pharmacological characterization of the anandamide cyclooxygenase metabolite: prostaglandin E2 ethanolamide. , 2002, The Journal of pharmacology and experimental therapeutics.

[16]  L. Marnett,et al.  Oxidative metabolism of endocannabinoids. , 2002, Prostaglandins, leukotrienes, and essential fatty acids.

[17]  J. Morrow,et al.  Metabolism of Prostaglandin Glycerol Esters and Prostaglandin Ethanolamides in Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[18]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[19]  L. Marnett,et al.  Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2* , 2000, The Journal of Biological Chemistry.

[20]  G. Prestwich,et al.  Using photolabile ligands in drug discovery and development. , 2000, Trends in biotechnology.

[21]  A. Howlett,et al.  Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils. , 1999, Advances in experimental medicine and biology.

[22]  A. Makriyannis,et al.  Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. , 1998, Journal of medicinal chemistry.

[23]  I. Fleming,et al.  Stereocontrol in organic synthesis using silicon-containing compounds. A formal synthesis of prostaglandins controlling the stereochemistry at C-15 using a silyl-to-hydroxy conversion following a stereochemically convergent synthesis of an allylsilane , 1998 .

[24]  C. Ramesha,et al.  Synthesis of Prostaglandin E2 Ethanolamide from Anandamide by Cyclooxygenase-2* , 1997, The Journal of Biological Chemistry.

[25]  P. Law,et al.  Irreversible Binding of cis-()-3-Methylfentanyl Isothiocyanate to the Opioid Receptor and Determination of Its Binding Domain (*) , 1996, The Journal of Biological Chemistry.

[26]  I. Akritopoulou‐Zanze,et al.  Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. , 1995, Biochemistry.

[27]  R. Vaughan.  Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping. , 1995, Molecular pharmacology.

[28]  A. Makriyannis,et al.  (-)-11-Hydroxy-7'-isothiocyanato-1',1'-dimethylheptyl-delta 8-THC: a novel, high-affinity irreversible probe for the cannabinoid receptor in the brain. , 1994, Journal of medicinal chemistry.

[29]  P. Mosset,et al.  New Syntheses of Some Functionalized and Acetylenic .beta.-Keto Phosphonates , 1994 .

[30]  M. Schneider,et al.  Enzymatic esterification of glycerol I. Lipase-catalyzed synthesis of regioisomerically pure 1,3-sn-diacylglycerols , 1992 .

[31]  A. Makriyannis,et al.  5'-Azido-delta 8-THC: a novel photoaffinity label for the cannabinoid receptor. , 1992, Journal of medicinal chemistry.

[32]  J. Luche,et al.  Lanthanoids in organic synthesis. 6. Reduction of .alpha.-enones by sodium borohydride in the presence of lanthanoid chlorides: synthetic and mechanistic aspects , 1981 .

[33]  J. Luche.  Lanthanides in organic chemistry. 1. Selective 1,2 reductions of conjugated ketones , 1978 .

[34]  H. Mosher,et al.  Nuclear magnetic resonance enantiomer regents. Configurational correlations via nuclear magnetic resonance chemical shifts of diastereomeric mandelate, O-methylmandelate, and .alpha.-methoxy-.alpha.-trifluoromethylphenylacetate (MTPA) esters , 1973 .

[35]  E. Corey,et al.  Stereo-controlled synthesis of dl-prostaglandins F2.alpha. and E2 , 1969 .